Glass Health vs UpToDate
The evaluation question is the whole story here, and each answers half of it. If your failure mode is a confident clinical answer nobody outside the company has ever checked, Glass submitted to the Harvard and Stanford ARISE NOHARM benchmark, a physician validated safety evaluation it did not control, and published where it placed. If your failure mode is a tool reasoning fluently past the edge of what it actually knows, UpToDate grounds every answer in its own expert authored corpus and opens each one by stating what it assumed about the patient. Both sit at B on governance for precisely opposite reasons: one has the measurement without a framework, the other published the framework and withheld every result. Start with Glass for reasoning and documentation in one workflow, UpToDate for institutional reach.
- Someone outside the company has checked it. Glass submitted to the Harvard and Stanford ARISE NOHARM evaluation, a physician validated clinical safety benchmark it did not control, and placed among the top medical AI systems. It also states publicly that its reasoning is strongest on common presentations and weaker on complex multi system cases. UpToDate has published no benchmark result of any kind for Expert AI, despite having published a public framework for evaluating clinical AI at the point of care.
- It does the reasoning and the documentation in a single pass, which UpToDate does not attempt. A ranked differential with suggested workups, a problem oriented assessment and plan drafted with inline evidence links, clinical question answering, and ambient scribing producing clinic notes, H and P notes, progress notes, discharge summaries and patient handouts. UpToDate answers the question and never touches the encounter. That difference is why Glass grades A on AI centrality against UpToDate's C.
- Compliance is executable rather than negotiable. Teams can review and accept a business associate agreement inside API settings before sending production PHI, which is the most concrete BAA mechanism anywhere in this segment and a materially different proposition from a BAA promised in a procurement cycle. UpToDate's HIPAA and BAA posture could not be established from public material at all and stands unrated on this index.
- Reach and institutional standing are not close. More than three million reported clinician users across thousands of hospitals, localised sites in over thirty countries, named Epic integration covering both decision support and patient education leaflets in up to nineteen languages. Glass's only retrievable adoption figure dates from 2023 and no named health system deployment, implementation shape or data residency statement could be located for it. UpToDate leads on both EHR depth and deployment.
- It tells you what it assumed and what it does not know. Every Expert AI response opens with a stated assumptions block naming what was taken for granted about the patient, and inline nudges ask the clinician to supply context the system lacks, such as comorbidities or ICU status. Set against a product whose own acknowledged weakness is complex multi system cases, an assistant that names its premises before answering is a real safeguard rather than a feature.
- You can establish what it costs, and the corpus has named owners. A public webstore sells personal and trainee subscriptions directly, with Expert AI included in all United States personal subscriptions, so a clinician can price the AI enabled product without speaking to anyone. And the grounding corpus is maintained by more than 7,600 named physician authors and editors under an editorial process, which is a different and more accountable model than an index of 38 million articles no one curated for this purpose.
Side-by-Side
| Axis | G Glass Health |
U UpToDate |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Read this grid knowing it moved substantially on 25 July 2026. Glass Health carried only 5 of 13 graded axes before this pass, four of them A grades, which made the record read as an unusually strong vendor purely because the harder compliance axes had never been attempted; eight axes were graded in this pass and the profile is now four A grades, four B, four C and one unrated. The Glass vendor record itself still carries a 6 July verification date and its description was not refreshed here. The ARISE NOHARM placement is recorded as at that 6 July verification and is vendor referenced rather than independently re verified in this pass, which matters because it is the single strongest claim on the record. Security is unrated on both sides and neither unrating is a finding. For Glass, two targeted searches for SOC 2, HITRUST, ISO 27001 or a trust centre returned nothing vendor specific. For UpToDate, the axis was never searched at its original build. Neither absence is evidence of weakness, and both are flagged for refresh, though it is worth noting that three peers in this same segment surface security attestations without being asked. Glass's terms of service and privacy policy were not opened in this pass, so its PHI stewardship grade rests on the published compliance frame rather than on retention, model training or deletion terms, which is a real limitation for a product that records patient encounters and offers a free individual tier. On the UpToDate side the evidence grade carries its own standing caveat: an older peer reviewed outcomes literature exists for the underlying content product and was not assessed, so that axis could move materially on refresh. Neither vendor publishes enterprise pricing. Finally, a source caution that cuts one way here: Glass Health publishes its own competitor comparison pages, including one on this index's other reference vendor, so its characterisations of UpToDate and OpenEvidence are self interested and were not used as evidence for any grade on this page.